Valuation: Medpace Holdings, Inc.

Market Cap 18.09B 16.5B 15.26B 13.77B 25.93B 1,691B 26.95B 184B 72.84B 913B 67.88B 66.46B 2,882B P/E 2026 *
35.5x
P/E 2027 * 33x
Enterprise Value 17.28B 15.76B 14.57B 13.15B 24.77B 1,615B 25.75B 176B 69.57B 872B 64.84B 63.48B 2,753B EV / Sales 2026 *
6.06x
EV / Sales 2027 * 5.57x
Free-Float
80.73%
Yield 2026 *
-
Yield 2027 * -
1 day-0.95%
1 week-2.69%
Current month-0.79%
1 month+4.59%
3 months+9.58%
6 months+53.77%
Current year+15.17%
1 week 639.21
Extreme 639.21
660.25
1 month 613.13
Extreme 613.13
693.97
Current year 373
Extreme 373
693.97
1 year 373
Extreme 373
693.97
3 years 250.05
Extreme 250.05
693.97
5 years 126.94
Extreme 126.945
693.97
10 years 21.76
Extreme 21.76
693.97
Manager TitleAgeSince
Chief Executive Officer 69 01/07/1992
Director of Finance/CFO 51 01/08/2021
Chief Tech/Sci/R&D Officer 65 01/09/2017
Director TitleAgeSince
Chairman 69 01/07/1992
Director/Board Member 55 01/07/2016
Director/Board Member 72 01/07/2016
Date Insider Type Main position Quantity % Market Cap. Importance
29/10/26 Sell

Compliance Officer

-1,245 0.0045%
27/10/26 Sell

Chief Operating Officer

-3,940 0.0141%
21/10/26 Exercice

Chief Operating Officer

5,400 0.0193%
Change 5-day change 1-year change 3-year change Capi.($)
-0.95%-2.69%+9.61%+136.08% 18.09B
-1.34%-3.09%+56.10%+68.83% 65.45B
-0.49%-3.54%+7.25%+89.75% 58.93B
+0.71%+0.75%+26.70%+87.85% 55.21B
-2.34%-3.90%+10.90%+115.97% 46.1B
+0.09%-6.08%+18.67%+25.90% 42.49B
-2.58%+0.24%+18.54%+41.28% 35.56B
-1.76%-11.56%+126.44%+649.27% 34.57B
+0.54%-0.42%+77.61%+58.33% 32.46B
-1.69%-0.79%-40.58%+382.68% 26.28B
Average -0.97%-3.33%+31.12%+165.59% 42B
Weighted average by Cap. -0.90%-3.26%+32.58%+143.12%

Financials

2026 *2027 *
Net sales 2.85B 2.6B 2.4B 2.17B 4.08B 266B 4.25B 29.02B 11.47B 144B 10.69B 10.47B 454B 3.02B 2.76B 2.55B 2.3B 4.33B 282B 4.5B 30.77B 12.16B 152B 11.33B 11.1B 481B
Net income 521M 475M 439M 396M 746M 48.64B 775M 5.3B 2.1B 26.26B 1.95B 1.91B 82.91B 554M 505M 467M 421M 794M 51.75B 825M 5.64B 2.23B 27.93B 2.08B 2.03B 88.2B
Net Debt -812M -740M -684M -618M -1.16B -75.85B -1.21B -8.27B -3.27B -40.94B -3.05B -2.98B -129B -1.27B -1.16B -1.07B -968M -1.82B -119B -1.9B -12.96B -5.12B -64.17B -4.77B -4.67B -203B
Projected Income Statement - Annual - Medpace Holdings, Inc.
Logo Medpace Holdings, Inc.
Medpace Holdings, Inc. is a scientifically driven, global, full-service clinical contract research organization (CRO) providing phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. The Company partners with pharmaceutical, biotechnology, and medical device companies in the development and execution of clinical trials. The Company's drug development services focus on full-service Phase I-IV clinical development services and include development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support. The Company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The Company's operations are principally based in North America, Europe, and Asia.
Employees
6,600
Date Price Change Volume
18/11/26 USD 646.87 -0.95% 211,746
17/11/26 USD 653.09 +0.75% 180,226
16/11/26 USD 648.20 -0.88% 230,405
13/11/26 USD 653.94 -0.44% 105,452
12/11/26 USD 656.84 -1.19% 142,184
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Medpace Holdings, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
646.87USD
Average target price
651.31USD
Spread / Average Target
+0.69%
  1. Stock Market
  2. Stocks
  3. MEDP Stock